Covalon Technologies Ltd. Highlights Clinical Innovation and Infection Prevention Leadership at Infusion Nurses Society 2026 Annual Meeting
Covalon Technologies Ltd., a company specializing in advanced medical technologies for wound care and infection prevention, has announced its participation in the Infusion Nurses Society 2026 Annual Meeting, taking place from April 11–14, 2026, in Louisville. The event is expected to bring together a wide range of healthcare professionals, including clinicians, researchers, and industry leaders, all focused on advancing best practices in vascular access and infusion therapy.
Covalon’s presence at the meeting reflects its growing role in supporting safer clinical environments through innovative solutions designed to reduce infection risks and improve patient outcomes. The company plans to use the event as a platform to showcase its expanding portfolio of vascular access protection technologies, as well as to engage with healthcare professionals on emerging challenges and solutions in infusion therapy.
A central theme of Covalon’s participation will be addressing a critical yet often underrecognized issue in clinical care: contamination of intravenous (IV) connections and access points. While vascular access devices are essential for delivering medications, fluids, and nutrition, they also represent a potential pathway for pathogens to enter the bloodstream. Even minor lapses in protection can lead to serious complications, including Catheter-Associated Bloodstream Infections (CABSIs), which are associated with increased morbidity, extended hospital stays, and higher healthcare costs.
Through a combination of clinical education, real-world data, and product innovation, Covalon Technologies Ltd. aims to demonstrate how targeted strategies can significantly reduce the risk of contamination. By focusing on practical solutions that can be integrated into everyday clinical workflows, the company seeks to empower healthcare providers to enhance patient safety without adding unnecessary complexity to their routines.
One of the highlights of the conference will be an educational session led by Nancy Moureau, a globally recognized authority in vascular access and infusion therapy. Her presentation, titled “A Closer Look at a ‘Gross’ Gap in Protection: What is Missing with CABSI?”, will examine the often-overlooked issue of gross contamination in IV connections and access points. The session will explore how routine clinical activities and environmental exposure contribute to infection risk, shedding light on gaps in current protective measures.
Dr. Moureau’s presentation will also provide evidence-based strategies to address these challenges, offering actionable insights that clinicians can apply in their daily practice. By highlighting the link between contamination and infection, the session aims to raise awareness and encourage the adoption of more comprehensive protection protocols.
At its exhibition booth, Covalon will feature its VALGuard® Vascular Access Line Guard, a product that has been gaining traction among hospitals and healthcare facilities focused on improving infection control. VALGuard is designed to provide an additional layer of protection for IV line connections, helping to minimize exposure to contaminants that could compromise patient safety. As healthcare systems increasingly prioritize infection prevention, solutions like VALGuard are becoming an integral part of vascular access management strategies.
In addition to VALGuard, Covalon Technologies Ltd. will showcase its CovaClear® IV Cover dressings, another key component of its infection prevention portfolio. These dressings are designed to shield primary IV sites from external contaminants such as bodily fluids and environmental debris commonly encountered in clinical settings. By protecting the integrity of primary dressings, CovaClear helps reduce the need for unplanned dressing changes, which can be both time-consuming and disruptive to patient care.
The ability to maintain a clean and secure IV site is critical for ensuring effective treatment and minimizing complications. Frequent dressing changes not only increase workload for healthcare staff but also expose patients to additional risks, including infection and discomfort. By providing a reliable protective barrier, CovaClear supports more efficient and consistent care practices, ultimately contributing to better patient outcomes.
Brent Ashton, Chief Executive Officer of Covalon Technologies Ltd., emphasized the importance of supporting frontline healthcare workers in their efforts to deliver safe and effective care. He noted that clinicians often bear the emotional and professional burden of patient outcomes, particularly when complications arise. Preventable infections, such as bloodstream infections, can have devastating consequences for patients and their families, as well as for the healthcare providers involved.
Ashton highlighted that many of these complications can be avoided with the right tools and protocols in place. Covalon’s mission, he explained, is to equip clinicians with practical solutions that enhance protection and reduce risk. By doing so, the company aims to help prevent adverse events and improve the overall quality of care delivered in hospitals and other healthcare settings.
The Infusion Nurses Society 2026 Annual Meeting provides an ideal setting for these discussions, as it brings together professionals who are directly involved in vascular access and infusion therapy. The event serves as a hub for knowledge exchange, allowing participants to share experiences, learn about new technologies, and explore strategies for improving patient care.
Attendees visiting Covalon’s booth (#610) will have the opportunity to engage with the company’s team, learn more about its product offerings, and discuss best practices for integrating contamination protection into routine care. These interactions are expected to foster collaboration and provide valuable insights into how healthcare providers can address ongoing challenges in infection prevention.
Beyond product demonstrations, Covalon’s presence at the conference underscores its broader commitment to advancing healthcare through innovation and education. By combining scientific research with practical applications, the company is working to bridge the gap between theory and practice, ensuring that new technologies translate into meaningful improvements in patient care.
As healthcare systems continue to face increasing demands and evolving challenges, the importance of infection prevention cannot be overstated. Initiatives like those presented by Covalon Technologies Ltd. highlight the critical role of innovation in addressing these challenges and supporting clinicians in their mission to deliver safe, high-quality care.
In summary, Covalon’s participation in the INS 2026 Annual Meeting reflects its dedication to improving vascular access safety through targeted solutions and collaborative engagement with the healthcare community. By raising awareness of contamination risks and offering effective tools to mitigate them, the company is contributing to a safer and more resilient healthcare environment for patients and providers alike.
About Covalon
Covalon is a leading MedTech company dedicated to improving patient outcomes through innovative and compassionate medical products and technologies. Our expertise spans advanced wound care, vascular access, and surgical consumables, with a strong focus on enhancing healing, reducing healthcare-associated infections (HAIs), and protecting skin integrity. Our solutions are designed for patients and made for care providers. The Company is listed on the TSX Venture Exchange (COV) and trades on the OTCQX Market (CVALF).
Source Link:https://www.businesswire.com/
